Weekly low dosage epirubicin in advanced breast cancer
- 31 December 1990
- journal article
- other
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (7), 847-848
- https://doi.org/10.1016/0277-5379(90)90170-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Effective palliation of advanced breast cancer with weekly low dose epirubicinEuropean Journal of Cancer and Clinical Oncology, 1989
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.Journal of Clinical Oncology, 1986
- Weekly-dose doxorubicin (WDA) in advanced breast cancerRadiotherapy and Oncology, 1986
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicityAmerican Journal of Clinical Oncology, 1983
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patientsCancer, 1980